EssilorLuxottica (OTCMKTS:ESLOY) Sees Strong Trading Volume – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw unusually-strong trading volume on Monday . 283,301 shares changed hands during mid-day trading, an increase of 129% from the previous session’s volume of 123,744 shares.The stock last traded at $95.86 and had previously closed at $95.00.

Analyst Ratings Changes

A number of research firms recently commented on ESLOY. Zacks Research lowered shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 23rd. Deutsche Bank Aktiengesellschaft assumed coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock. Finally, The Goldman Sachs Group downgraded shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

EssilorLuxottica Stock Performance

The stock has a 50-day moving average price of $99.44 and a two-hundred day moving average price of $120.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.